{"nctId":"NCT00132873","briefTitle":"Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy","startDateStruct":{"date":"2004-10"},"conditions":["Narcolepsy"],"count":59,"armGroups":[],"interventions":[{"name":"Xyrem (sodium oxybate) oral solution","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Remained on satisfactory treatment with Xyrem® therapy in the OMC-SXB-7 trial\n* Signed and dated an informed consent","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Adverse Experiences","description":"Number of Subjects with treatment-emergent adverse events.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null}]}]}]},{"type":"PRIMARY","title":"Vital Signs","description":"Average Respiratory Rate at 1 year.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.0","spread":"2.40"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":11,"n":58},"commonTop":["Nasopharyngitis","Urinary Tract Infection","Hypertension","Influenza","Pain In Extremity"]}}}